Dalteparin Multi-Dose Vials and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Dalteparin Multi-Dose Vials and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dalteparin
Brand name: Fragmin
Synonyms: Dalteparin
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dalteparin Multi-Dose Vials-Lithium ER
- Dalteparin Multi-Dose Vials-Lithium Oral Solution
- Dalteparin Multi-Dose Vials-Lithium Salts
- Dalteparin Multi-Dose Vials-Lithium Syrup and Oral Solution
- Dalteparin Multi-Dose Vials-Lithobid
- Dalteparin Multi-Dose Vials-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Dalteparin Sodium
- Lithium Controlled-Release and Extended-Release Tablets-Dalteparin Subcutaneous
- Lithium Controlled-Release and Extended-Release Tablets-Dalvance
- Lithium Controlled-Release and Extended-Release Tablets-Danaparoid
- Lithium Controlled-Release and Extended-Release Tablets-Danaparoid Subcutaneous
- Lithium Controlled-Release and Extended-Release Tablets-Danazol